One of the largest pharma companies in the world moved to boost its cancer immunotherapy pipeline. The all-cash acquisition, which is expected to close in the second quarter of 2018, gives Eli Lilly a ...

TEL AVIV, Israel, Feb. 7, 2023 /PRNewswire/ -- ARMO, creator of open-source Kubernetes security platform Kubescape, announced today that it has integrated ChatGPT's generative AI into ARMO Platform.

ARMO CADR minimizes the cloud attack surface, detects and responds to unknown and known cyberattacks while ensuring business continuity, combining the power of CDR and ADR solutions ARMO, the leading ...

ARMO, the Tel Aviv-based company behind Kubescape, the popular open source Kubernetes security platform, today announced that it has raised a $30 million Series A funding round led by Tiger Global.

Last year, Eli Lilly spent $1.6 billion to get its hands on Armo Biosciences and its lead asset, pegilodecakin. Today, that drug flopped. To be fair to Armo and Lilly, the target was tough, arguably ...

ARMO BioSciences has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). The company intends to price its 6.67 million shares ...

ARMO, developers of a platform that inherently secures cloud-native workloads with in-memory protection coupled with built-in visibility and control, is emerging from stealth after securing $4.5 ...

Eli Lilly plans to acquire Armo BioSciences for approximately $1.6 billion, the companies said today, in a deal that builds the buyer’s immuno-oncology pipeline with a Phase III pancreatic cancer ...

ARMO Ltd., the cloud runtime security company behind the open-source Kubernetes security platform Kubescape, today announced the launch of Behavioral Cloud Application Detection and Response, a new ...

Shares of ARMO Biosciences (NASDAQ: ARMO) soared as much as 67.6% after the company announced that it was acquired by Eli Lilly (NYSE: LLY) for $1.6 billion. The formerly small-cap biopharma wields a ...